Tuesday, June 18, 2013
"For years, spine surgeons praised Medtronic’s Infuse in helping to speed healing and reduce pain after spinal fusion surgeries"
That's the lede in the Strib's article on the latest development in Infuse scandal. Inexplicably, the article fails to mention that the chair of spine surgery at the U, David Polly, was one of those surgeons, and that he was investigated by the Senate Finance Committee for failing to disclose $1.14 million in payments from Medtronic. You can read about it in the New York Times, or in back issues of the Strib, when Janet Moore had the device industry beat. (See this, or this, or this.)
Posted by Carl at 7:41 AM